Toronto Dominion Bank Karuna Therapeutics, Inc. Transaction History

Toronto Dominion Bank

  • $55.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Feb 14, 2024
BUY
$176.32 - $240.22 $7,052 - $9,608
40 New
40 $9,000
Q2 2023

Aug 10, 2023
BUY
$176.32 - $240.22 $7,052 - $9,608
40 New
40 $9,000
Q1 2022

May 09, 2022
SELL
$98.9 - $132.37 $1.23 Million - $1.64 Million
-12,397 Closed
0 $0
Q4 2021

Feb 04, 2022
BUY
$110.64 - $159.4 $1.37 Million - $1.98 Million
12,397 New
12,397 $1.62 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email